Data / Form D filings / Ionetix Corp / DE /
Ionetix Corp / DE /: Form D filing
Ionetix Corp / DE /, a pharmaceuticals company in Lansing, MI, filed a Form D with the SEC in 2026. The latest, on April 23, 2026, reports $32.3 million sold of a $32.3 million offering to 267 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 3130 SOVEREIGN DRIVE, SUITE 5D, Lansing, MI, 48911
- Phone
- (517) 752-4069
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 2108121
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Apr 23, 2026 | New notice | $32,331,837 | $32,331,837 | 267 | Apr 9, 2026 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Kevin Cameron | Executive Officer | Chief Executive Officer |
| Phieu Phun | Executive Officer | Chief Financial Officer |
| Gregory Martin | Director | |
| Douglas Boothe | Director | |
| Michael Stewart | Executive Officer, Director | Executive Chairman |
| David Landskowsky | Director |
Other pharmaceuticals companies in Michigan that filed recently
- IMACS Working Capital Facility One LLC $200,000 · Sep 17, 2026
Every Form D from the week of Apr 20, 2026 · All recent filings in Michigan · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Ionetix Corp / DE / reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.